Botulinum toxin: The overall cure for defective relaxation?

Endoscopy

Volumn 31, Issue 5, 1999, Pages 392-397

  Thumshirn, M ^a   Fried, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ANUS FISSURE; ANUS SPHINCTER DISORDER; CONSTIPATION; DRUG CONTRAINDICATION; ESOPHAGUS ACHALASIA; ESOPHAGUS DILATATION; ESOPHAGUS FUNCTION DISORDER; GASTROINTESTINAL DISEASE; HIRSCHSPRUNG DISEASE; HUMAN; MUSCLE RELAXATION; MYOTOMY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; VATER PAPILLA STENOSIS;

ANTI-DYSKINESIA AGENTS; ANUS DISEASES; BOTULINUM TOXINS; COMMON BILE DUCT DISEASES; ESOPHAGEAL MOTILITY DISORDERS; GASTROINTESTINAL MOTILITY; HUMANS; SPHINCTER OF ODDI; TREATMENT OUTCOME;

EID: 0033050905     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-33     Document Type: Review

References (59)

1. National Institute of Health. Consensus conference, November 1990: clinical use of botulinium toxin. Conn Med 1991; 55: 471-6
2. Scott AB. Botulinum toxin injections into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 1980; 87: 1044-9
3. Simpson LL. The origin, structure, and pharmacologic activity of botulinium toxin. Pharmacol Rev 1981; 33: 155-88
4. Montecucco C, Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 1994; 13: 1-8
5. MacKenzie J, Burnstock G, Dolly JO. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neurosience 1982; 7: 997-1006
6. Bigalke H, Habermann E. Blockade of tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol 1980; 312: 255-63
7. Wiegand H, Wellhorner HH. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedebergs Arch Pharmacol 1976; 292: 161-5
8. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991; 324: 1186-94
9. Schwartz KS, Jankovic J. Predicting the response to botulinum toxin injections for the treatment of cervical dystonia (abstract). Neurology 1990; 40: 382
10. Siatkowski RM, Tyutyunikov A, Biglan AW, et al. Serum antibody production to botulinum A toxin. Ophthalmology 1993; 100: 1861-6
11. Janssens J, Annese V, Vantrappen G. Medical treatment of primary esophageal motility disorders. Minerva Dietal Gastroenterol 1990; 36: 145-55
12. Pasricha PJ, Ravich WJ, Kalloo AN. Effects of intrasphincteric botulinum toxin on the lower esophageal spincter in piglets. Gastroenterology 1993; 105: 1045-49
13. Pasricha PJ, Ravich WJ, Hendrix TR, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Ann Intern Med 1994; 121: 590-1
14. Pasricha PJ, Ravich WJ, Hendrix TR, et al. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med 1995; 332: 774-8
15. Annese V, Basciani M, Perri F, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology 1996; 111: 1418-24
16. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 1996; 110: 1410-5
17. Cuillière C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41: 87-92
18. Gordon JM, Eaker EY. A prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. Am J Gastroenterol 1997; 92: 1812-7
19. Fishman VM, Parkman HP, Schiano TD, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91: 1724-30
20. Jin HO, Potter GD, Shah AN, et al. Effect of intrasphincteric injection of botulinum toxin on esophageal motility in achalasia (abstract). Gastroenterology 1995; 108: A123
21. Waterfall WE, Tougas G, Fachnie B, et al. Clinical and manometric response to botulinum toxin used as a primary treatment for achalasia (abstract). Gastroenterology 1995; 108: A255
22. Bansal R, Scheiman JM, Barnett JL, et al. Intrasphincteric injection of botulinum toxin for achalasia (abstract). Gastroenterology 1995; 108: A54
23. Greaves RR, Mulcahy HE, Patchett PD, et al. Botulinum toxin in the treatment of achalasia: a promise unfulfilled (abstract). Gastroenterology 1996; 110: A123
24. Birgisson S, Richter JE. Long-term outcome of botulinum toxin in the treatment of achalasia (letter). Gastroenterology 1996; 111: 1162
25. Annese V, D'Onofrio V, Andriulli A. Botulinum toxin in long-term therapy for achalasia (letter). Ann Intern Med 1998; 128: 696
26. Eaker EY, Gordon JM, Vogel SB. Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Dig Dis Sci 1997; 42: 724-7
27. Vantrappen G, Hellemans J. Treatment of achalasia and related motor disorders. Gastroenteroloy 1980; 79: 144-54
28. Katz P. Achalasia: two effective treatment options - let the patient decide. Am J Gastroenterol 1994; 89: 969-70
29. Malthaner RA, Todd TR, Miller L, Pearson FG, Long-term results in surgically managed esophageal achalasia. Ann Thorac Surg 1994; 58: 1343-6
30. Schwartz HM, Cahow CE, Traube M. Outcome after perforation sustained during pneumatic dilatation for achalasia. Dig Dis Sci 1993; 38: 1409-13
31. Abid S, Champion G, Richter JE. Treatment of achalasia: the best of both worlds. Am J Gastroenterol 1994; 89: 979-85
32. Panaccione R, Gregor JC, Reynolds RPE, Preiksaitis HG. A cost minimization analysis of intrasphincteric botulinum toxin versus pneumatic dilatation in patients with achalasia (abstract). Gastroenterology 1997; 112: A250
33. Choudry U, Boyce HW. A prospective study of the efficacy of botulinum toxin A (BTX) in patients with epiphrenic diverticula (abstract). Am J Gastroenterol 1996; 91: 1885
34. Wehrmann T, Kokabpick H, Jacobi V, et al. Endoskopische Botulinus Toxin Injektion zur Behandlung von "Hochrisiko"-Achalasie-Patienten (abstract). Z Gastroenterol 1998; 36: 726
35. Annese V, Basciani M, Lombardi G, et al. Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc 1996; 44: 461-5
36. Miller LS, Parkman HP, Schiano TD, et al. Treatment of symptomatic nonachalasia esophageal motility disorders with botulinum toxin injection at the lower esophageal sphincter. Dig Dis Sci 1996; 41: 2025-31
37. Cassidy MJ, Schiano TD, Adrian AL, et al. Botulinum toxin injection for the treatment of symptomatic diffuse esophageal spasm (abstract). Am J Gastroenterol 1996; 91: 1884
38. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. Gastroenterology 1991; 101: 1068-75
39. Guelrud M, Mendoza S, Viera L, et al. Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 1991; 37: 44-7
40. Goff JS. Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction. Am J Gastroenterol 1995; 90: 586-9
41. Pasticha PJ, Miskovsky EP, Kalloo AN. Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 1994; 35: 1319-21
42. Wehrmann T, Seifert H, Seipp M, et al. Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. Endoscopy 1998; 30: 702-7
43. Muehldorfer SM, Hahn EG, Ell C. Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis. Endoscopy 1997; 29: 120-4
44. Arabi Y, Alexander-Williams J, Keighley MRB. Anal pressures in hemorrhoids and anal fissure. Ann J Surg 1977; 134: 608-10
45. Notham BJ, Schuster MM. Internal anal sphincter derangement with anal fissure. Gastroenterology 1974; 67: 216-30
46. Gibbons CP, Read NW. Anal hypertonia in fissures: cause or effect? Br J Surg 1986; 73: 443-5
47. Mason PF, Watkins MJG, Hall HS, Hall AW. The management of chronic fissure in ano with botulinum toxin. J R Coll Surg Edinb 1996; 41: 235-8
48. Weaver RM, Ambrose NS, Alexander-Williams J, Keighley MRB. Manual dilatation of the anus vs. lateral sphincterotomy in the treatment of chronic fissure in ano: results of a prospective, randomized, clinical trial. Dis Colon Rectum 1987; 30: 420-3
49. Maria G, Cassetta E, Daniele G, et al. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med 1998; 338: 217-20
50. Gorfine SR. Topical nitroglycerin therapy for anal fissure and ulcers. N Engl J Med 1995; 333: 1156-7
51. Watson SJ, Kamm MA, Nichols RJ, Phillips RKS. Topical glyceryl trinitrate in the treatment of chronic anal fissure. Br J Surg 1996; 83: 771-5
52. Lund JN, Armitage NC, Scholefield JH. Use of glyceryl trinitrate ointment in the treatment of anal fissure. Br J Surg 1996; 83: 776-7
53. Klosterhalften B, Vogel P, Rixen H, Mittermayer C. Topography of the inferior rectal artery: a possible cause of chronic primary anal fissure. Dis Colon Rectum 1989; 32: 43-52
54. Jost WH. One hundred cases of anal fissure treated with botulinum toxin. Dis Colon Rectum 1997; 40: 1029-32
55. Gui D, Cassetta E, Anastasio G, et al. Botulinum toxin for chronic anal fissure. Lancet 1994; 344: 1127-8
56. Birkenfeld S, Ron Y, Rozen A, et al. Treatment of anal fissure with botulinum toxin injections (abstract). Gastroenterology 1997; 112: A4
57. Hallan RI, Williams NS, Melling J, et al. Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 1988; 2: 714-7
58. Enck P. Biofeedback training in disordered defecation: a critical review. Dig Dis Sci 1993; 38: 1953-60
59. Langer JC, Birnbaum E. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation. J Pediatr Surg 1997; 32: 1059-6